On 26 September 2017, Angelfish Investments plc (“Angelfish”) announced that the Company had entered into an agreement to provide a loan facility to Rapid Nutrition Plc (“Rapid”).
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established on the back of its successful and proven weight loss supplement range which is exported worldwide, and now offers consumers a growing range of health and wellbeing solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. http://www.rnplc.com/
Rapid is presently listed on the SIX Swiss Exchange, Zurich and has appointed corporate advisors with a view of working towards obtaining a listing in London.
In the first instance the loan provided by Angelfish to Rapid is in the amount of £150,000 and interest bearing at 10% per annum until 28 February 2018. The loan, plus rolled-up interest, is automatically convertible into Rapid ordinary shares immediately prior to an admission of Rapid ordinary shares to a listing on a recognised investment exchange as defined by the FCA (“Admission”), at a price of 13.32p per share, provided Admission occurs by 28 February 2018.